Navellier & Associates Inc. lifted its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 32.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,660 shares of the medical research company’s stock after buying an additional 904 shares during the quarter. […]